Jefferies Group LLC set a $110.00 target price on athenahealth, Inc. (NASDAQ:ATHN) in a report released on Friday morning. The firm currently has a hold rating on the health services provider’s stock. Jefferies Group also issued estimates for athenahealth’s FY2018 earnings at $1.23 EPS.
A number of other research firms also recently commented on ATHN. ValuEngine upgraded athenahealth from a sell rating to a hold rating in a research report on Monday, July 24th. Evercore ISI reiterated an outperform rating and set a $163.00 target price (up from $155.00) on shares of athenahealth in a research report on Saturday, July 22nd. Cowen and Company downgraded athenahealth from an outperform rating to a market perform rating and increased their target price for the company from $127.00 to $133.00 in a research report on Monday, July 31st. Stifel Nicolaus reiterated a hold rating and set a $151.00 target price (up from $106.00) on shares of athenahealth in a research report on Friday, June 16th. Finally, KeyCorp reiterated a buy rating and set a $170.00 target price on shares of athenahealth in a research report on Sunday, September 17th. Three investment analysts have rated the stock with a sell rating, twelve have given a hold rating and twelve have assigned a buy rating to the stock. The company presently has an average rating of Hold and an average price target of $149.48.
Shares of athenahealth (NASDAQ ATHN) opened at 115.33 on Friday. athenahealth has a one year low of $90.11 and a one year high of $158.66. The stock has a 50 day moving average of $127.86 and a 200-day moving average of $130.33. The company has a market capitalization of $4.61 billion, a price-to-earnings ratio of 146.36 and a beta of 1.76.
athenahealth (NASDAQ:ATHN) last posted its earnings results on Thursday, July 20th. The health services provider reported $0.51 EPS for the quarter, beating analysts’ consensus estimates of $0.39 by $0.12. The firm had revenue of $301.10 million during the quarter, compared to the consensus estimate of $298.68 million. athenahealth had a return on equity of 6.91% and a net margin of 2.80%. The company’s quarterly revenue was up 15.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.34 EPS. On average, equities analysts expect that athenahealth will post $1.91 earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: This report was published by Stock Observer and is the sole property of of Stock Observer. If you are viewing this report on another website, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The original version of this report can be viewed at https://www.thestockobserver.com/2017/10/17/jefferies-group-llc-analysts-give-athenahealth-inc-athn-a-110-00-price-target.html.
In other news, SVP Jonathan D. Porter sold 422 shares of the firm’s stock in a transaction on Friday, July 21st. The stock was sold at an average price of $154.00, for a total transaction of $64,988.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Jonathan Bush sold 4,000 shares of the firm’s stock in a transaction on Tuesday, August 1st. The shares were sold at an average price of $143.31, for a total value of $573,240.00. Following the transaction, the chief executive officer now owns 319,807 shares in the company, valued at approximately $45,831,541.17. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 16,205 shares of company stock worth $2,197,912. Insiders own 3.20% of the company’s stock.
Institutional investors and hedge funds have recently bought and sold shares of the business. Elliott Management Corp purchased a new position in athenahealth in the second quarter valued at about $52,706,000. Scout Investments Inc. grew its stake in athenahealth by 67.2% in the second quarter. Scout Investments Inc. now owns 115,663 shares of the health services provider’s stock valued at $16,256,000 after purchasing an additional 46,507 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in athenahealth by 1.7% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 72,918 shares of the health services provider’s stock valued at $10,249,000 after purchasing an additional 1,222 shares during the last quarter. Schwab Charles Investment Management Inc. grew its stake in athenahealth by 6.2% in the second quarter. Schwab Charles Investment Management Inc. now owns 170,978 shares of the health services provider’s stock valued at $24,031,000 after purchasing an additional 9,960 shares during the last quarter. Finally, BlackRock Inc. grew its stake in athenahealth by 30,642.6% in the first quarter. BlackRock Inc. now owns 1,599,847 shares of the health services provider’s stock valued at $180,286,000 after purchasing an additional 1,594,643 shares during the last quarter.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.